BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3037174)

  • 21. Endopeptidase-24.11 is striosomally ordered in pig brain and, in contrast to aminopeptidase N and peptidyl dipeptidase A ('angiotensin converting enzyme'), is a marker for a set of striatal efferent fibres.
    Barnes K; Matsas R; Hooper NM; Turner AJ; Kenny AJ
    Neuroscience; 1988 Dec; 27(3):799-817. PubMed ID: 2908057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence of angiotensin-converting enzyme activator in bovine tissues.
    Elisseeva YuE ; Sinanjan ES; Kugaevskaja EV
    Biochem Mol Biol Int; 1994 Jan; 32(1):173-80. PubMed ID: 8012283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory peptide metabolism at cell surfaces: the key role of endopeptidase-24.11.
    Kenny AJ
    Biomed Biochim Acta; 1986; 45(11-12):1503-13. PubMed ID: 3555472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ramipril and cardiac and renal angiotensin converting enzyme].
    Grima M; Stephan D; Welsch C; Coquard C; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():43-8. PubMed ID: 7646311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic and regional hemodynamic effects of a new angiotensin converting enzyme and neutral endopeptidase mixed inhibitor, alatriopril, in the dog].
    Richard V; Lecomte JM; Thuillez C
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1275-9. PubMed ID: 8129543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the role of angiotensin-converting enzyme in renal function and blood pressure control through the analysis of genetically modified mice.
    Bernstein KE; Xiao HD; Adams JW; Frenzel K; Li P; Shen XZ; Cole JM; Fuchs S
    J Am Soc Nephrol; 2005 Mar; 16(3):583-91. PubMed ID: 15659560
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of isorenin and angiotensin-converting enzyme in the eyeball].
    Hăulică I; Stratone A; Roşca V; Bîrsan S; Boişteanu D
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(3):499-502. PubMed ID: 2832920
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma renin activity and changes in tissue angiotensin converting enzyme.
    Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
    J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme 2 and the kidney.
    Soler MJ; Wysocki J; Batlle D
    Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase.
    Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
    Biochemistry; 1998 Feb; 37(6):1680-5. PubMed ID: 9484239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
    Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic stability of the LHRH antagonist antide to cell-surface peptidases.
    Medeiros Mdos S; Turner AJ; Ljungqvist A; Folkers K
    Biochem Biophys Res Commun; 1991 Apr; 176(1):25-30. PubMed ID: 2018520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites.
    Roques BP; Fournié-Zaluski MC; Florentin D; Waksman G; Sassi A; Chaillet P; Collado H; Costentin J
    Life Sci; 1982 Oct 18-25; 31(16-17):1749-52. PubMed ID: 6296575
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat brain enkephalinase: characterization of the active site using mercaptopropanoyl amino acid inhibitors, and comparison with angiotensin-converting enzyme.
    Gordon EM; Cushman DW; Tung R; Cheung HS; Wang FL; Delaney NG
    Life Sci; 1983; 33 Suppl 1():113-6. PubMed ID: 6319849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced granuloma angiotensin I converting enzyme activity associated with modulation in murine schistosomiasis.
    Weinstock JV; Boros DL; Gee JB
    Gastroenterology; 1981 Jul; 81(1):48-53. PubMed ID: 6263744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.